Browsing by Author "Keskin Tunc, Serap"

Now showing 1 - 3 of 3

Can Extracorporeal Shock Wave Therapy Be Effective in Temporomandibular Joint Disorder?: a Pilot Study
(Lippincott Williams & Wilkins, 2024) Keskin Tunc, Serap; Unalan Degirmenci, Beyza; Bilen, Mustafa; Toprak, Mehmet Emin; Kaplan, Sehmus; Turan, Mahfuz
Background:This study aimed to compare extracorporeal shock wave therapy (ESWT) with the use of stabilization splint in nonsurgical temporomandibular disorders treatments, and to evaluate the effects.Methods:In this study, individuals, who are diagnosed with disc displacements with reduction according to the diagnostic criteria for temporomandibular disorder examination criteria. The patients in the first control group (n = 36) were applied a medical treatment + stabilization splint. The second group (n = 25) was applied the ESWT (2 days a week for 4 weeks) + medical treatment + stabilization splint. Visual Analog Scale scores, painless maximum painless mouth opening, and passive-forced mouth opening measurements were recorded for the first and second weeks.Results:The ESWT application significantly contributed to pain-reducing (Visual Analog Scale) in patients at short notice (P = .030) in the second group. There were statistically significant differences between the groups in painless maximum active mouth opening (P = .009) and passive forced measurements (P = .004) in the second week.Conclusion:This pilot study showed that short-term ESWT addition to stabilization splint and medical treatment may yield satisfactory outcomes.
Comparison of Single-Needle Double-Cannula and Double-Needle Arthrocentesis Techniques in the Disc Displacement without Reduction: A Pilot Study
(Taylor & Francis Ltd, 2025) Keskin Tunc, Serap; Mizrak, Yusuf Rodi; Baskan Onal, Asli; Sumer, Selin; Atay, Gulsan; Cigerim, Levent
The aim of this study was to compare the clinical success and efficacy of single-needle double-cannula (SNDC) and double-needle (DN) arthrocentesis in patients with temporomandibular joint (TMJ) disc displacement without reduction (DDwoR).Materials and MethodsThis pilot study included 28 patients with DDwoR who did not receive prior treatment. Data including age, sex, pain duration, maximum mouth opening (MMO), and pain perception were recorded. We performed arthrocentesis once for each indicated joint. Data were collected before arthrocentesis (baseline) and at one week and one, three, and six months after the procedure.ResultsThirteen patients underwent SNDC arthrocentesis, and 15 underwent DN arthrocentesis. The mean MMO was significantly greater in the SNDC group (38.38 +/- 3.88) than in the DN group (34.33 +/- 5.92) at six months (p = 0.040). The mean VAS pain scores were significantly higher in the SNDC group (5.90 +/- 1.85) than in the DN group (3.53 +/- 2.23) at one week (p = 0.011).ConclusionBoth techniques improved MMO and pain; SNDC may provide greater long-term MMO improvement, while DN may offer superior early pain relief.
Erbium, Chromium-Doped: Yttrium, Scandium, Gallium, Garnet and Diode Lasers in the Treatment of Peri-Implantitis: Clinical and Biochemical Outcomes in a Randomized-Controlled Clinical Trial
(Springer London Ltd, 2022) Alpaslan Yayli, Nazli Zeynep; Talmac, Ahmet Cemil; Keskin Tunc, Serap; Akbal, Damla; Altindal, Dicle; Ertugrul, Abdullah Seckin
This study aims to evaluate the effects of 940 nm diode laser and 2780 nm erbium, chromium-doped: yttrium, scandium, gallium, garnet (Er,Cr:YSGG) laser used in addition to mechanical therapy in the non-surgical treatment of peri-implantitis on clinical parameters and matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) levels in the peri-implant crevicular fluid. A total of 50 patients with peri-implantitis were randomized into three groups to receive peri-implant treatment. The control group (n = 17) only received conventional non-surgical mechanical therapy. The trial groups [(diode group (n = 16) and Er,Cr:YSGG group (n = 17)] received dental laser in addition to mechanical therapy. Gingival index (GI), plaque index (PI), bleeding on probing, probing depth (PD), MMP-9, and TIMP-1 levels were assessed at baseline (T0) and at 6 months after treatment (T1). The GI, PI, and PD significantly decreased in all groups at T1, compared to T0 (p < 0.05). The decrease in the PD was similar between the control and diode groups with Er,Cr:YSGG providing more reduction (1.16 +/- 0.64 mm) than either method (p = 0.032). A significant intra-group decrease in MMP-9 level was only observed in the Er,Cr:YSGG group (p = 0.009). The decrease in TIMP-1 level from T0 to T1 was similar between the control and the diode groups (p > 0.05) and it was significantly lower than the decrease in the Er,Cr:YSGG group (p < 0.05). Addition of diode laser to non-surgical mechanical therapy does not provide any additional benefit for treatment outcomes. The Er,Cr:YSGG laser seems to be more efficient both at clinical and molecular levels.